Outcomes from screening review meeting
| Outcome | Reason | Action | Communication |
| Normal | No abnormal findings—no action required | Discharge | Patients and GPs sent letter communicating result |
| Benign urological and non-urological findings | Benign findings—no action required | Discharge | Patients and GPs sent letter communicating benign findings and that no further action is required |
| Indeterminate benign finding | Indeterminate finding requiring further elective investigations | Referral to appropriate specialty coordinated by Consultant Urologist and their delegates. Further tests requested as appropriate following recommendations by radiologist. | YKST lead nurse telephones patients (except for adrenal referrals where referral team contacts patients immediately after the referral is made). Patients then contacted by relevant specialty administrative team scheduling appointment and copy sent to GP. |
| Possible malignancy outside the renal tract or AAA | Abnormality requiring immediate further investigation for possible abdominal cancer or AAA | Fast Track 2-week wait appropriate specialty coordinated by Consultant Urologist and their delegates. | YKST lead nurse contacts patients explaining findings, need for further investigations or onward referral. Patients then contacted by relevant specialty administrative team scheduling appointment and copy sent to GP. |
| Possible renal/urological cancer | Abnormality requiring immediate further investigation for possible renal or urological cancer | During YKST scan review meeting: Consultant Urologist or delegates request contrast scan, refer patient to urology multi-disciplinary team meeting (MDT) and assign them to fast track 2-week wait pathway. | YKST lead nurse telephone patients explaining findings and need for further investigations. Patients then contacted by relevant specialty administrative team scheduling appointment and copy sent to GP. |
AAA, abdominal aortic aneurysm; GP, general practice; YKST, Yorkshire Kidney Screening Trial.